I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| astrocyte | 5 studies | 22% ± 3% | |
| type I pneumocyte | 4 studies | 22% ± 5% | |
| GABAergic neuron | 3 studies | 23% ± 6% | |
| glutamatergic neuron | 3 studies | 29% ± 7% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| astrocyte | 5 studies | 22% ± 3% | |
| type I pneumocyte | 4 studies | 22% ± 5% | |
| GABAergic neuron | 3 studies | 23% ± 6% | |
| glutamatergic neuron | 3 studies | 29% ± 7% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 20% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 100% | 1530.16 | 459 / 459 | 100% | 43.37 | 1117 / 1118 |
| lung | 100% | 2092.31 | 577 / 578 | 100% | 25.32 | 1154 / 1155 |
| brain | 99% | 1328.81 | 2626 / 2642 | 100% | 59.21 | 705 / 705 |
| thymus | 100% | 1227.22 | 651 / 653 | 99% | 24.45 | 600 / 605 |
| prostate | 100% | 1168.71 | 244 / 245 | 99% | 17.75 | 498 / 502 |
| uterus | 100% | 2343.93 | 170 / 170 | 99% | 17.84 | 453 / 459 |
| kidney | 100% | 1124.03 | 89 / 89 | 99% | 25.74 | 888 / 901 |
| ovary | 100% | 1703.06 | 180 / 180 | 98% | 16.29 | 423 / 430 |
| esophagus | 98% | 1920.64 | 1421 / 1445 | 99% | 20.19 | 182 / 183 |
| bladder | 100% | 833.10 | 21 / 21 | 97% | 20.86 | 491 / 504 |
| intestine | 100% | 1716.80 | 966 / 966 | 96% | 18.09 | 508 / 527 |
| skin | 99% | 1062.89 | 1792 / 1809 | 94% | 18.31 | 445 / 472 |
| liver | 97% | 817.38 | 219 / 226 | 95% | 16.10 | 384 / 406 |
| stomach | 92% | 772.05 | 332 / 359 | 98% | 19.10 | 279 / 286 |
| adrenal gland | 95% | 843.46 | 246 / 258 | 93% | 15.20 | 215 / 230 |
| pancreas | 79% | 397.59 | 260 / 328 | 99% | 19.13 | 176 / 178 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 17.73 | 29 / 29 |
| spleen | 100% | 909.94 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 15.90 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 37.27 | 1 / 1 |
| adipose | 100% | 1821.66 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 1655.94 | 1333 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 100% | 1125.75 | 799 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 94% | 1507.50 | 870 / 929 | 0% | 0 | 0 / 0 |
| heart | 92% | 831.72 | 792 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 76% | 9.43 | 61 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0007165 | Biological process | signal transduction |
| GO_0051321 | Biological process | meiotic cell cycle |
| GO_0030308 | Biological process | negative regulation of cell growth |
| GO_0005575 | Cellular component | cellular_component |
| GO_0008083 | Molecular function | growth factor activity |
| GO_0003674 | Molecular function | molecular_function |
| Gene name | OSGIN2 |
| Protein name | Oxidative stress induced growth inhibitor family member 2 Oxidative stress-induced growth inhibitor 2 (hT41) |
| Synonyms | C8orf1 |
| Description | FUNCTION: May be involved in meiosis or the maturation of germ cells. |
| Accessions | ENST00000297438.6 [Q9Y236-1] E5RJZ3 ENST00000647849.1 [Q9Y236-1] ENST00000520659.1 ENST00000451899.7 [Q9Y236-2] Q9Y236 |
